IRadimed Corp (IRMD) stock
IRMDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 19/3037% above fair value
$81.26−1.05 (-1.28%)
Close on Nov 19, 2026Market cap $1.04BP/E 43.5Yield –
IRadimed gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
IRadimed's gross profit for the twelve months ending Sep 30, 2026 was $67.46M, up 8.7% year over year. For fiscal 2025 it was $64.32M, up 14.2% from the year before. Over ten years it grew 9.6% a year on average. The highest annual figure on record is $64.32M in fiscal 2025.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $64.32M | +14.2% |
| FY2024 | Dec 31, 2024 | $56.35M | +12.3% |
| FY2023 | Dec 31, 2023 | $50.16M | +21.5% |
| FY2022 | Dec 31, 2022 | $41.28M | +28.8% |
| FY2021 | Dec 31, 2021 | $32.05M | +36.0% |
| FY2020 | Dec 31, 2020 | $23.57M | -20.6% |
| FY2019 | Dec 31, 2019 | $29.70M | +27.9% |
| FY2018 | Dec 31, 2018 | $23.23M | +32.6% |
| FY2017 | Dec 31, 2017 | $17.51M | -33.5% |
| FY2016 | Dec 31, 2016 | $26.34M | +2.3% |
| FY2015 | Dec 31, 2015 | $25.75M | +110.3% |
| FY2014 | Dec 31, 2014 | $12.25M | +44.3% |
| FY2013 | Dec 31, 2013 | $8.49M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $18.46M | +11.9% |
| Q2 FY2026 | Jun 30, 2026 | $15.16M | -5.0% |
| Q1 FY2026 | Mar 31, 2026 | $16.81M | +13.3% |
| Q4 FY2025 | Dec 31, 2025 | $17.03M | +15.4% |
| Q3 FY2025 | Sep 30, 2025 | $16.49M | +16.2% |
| Q2 FY2025 | Jun 30, 2025 | $15.96M | +13.9% |
| Q1 FY2025 | Mar 31, 2025 | $14.84M | +10.9% |
| Q4 FY2024 | Dec 31, 2024 | $14.76M | +10.1% |
| Q3 FY2024 | Sep 30, 2024 | $14.19M | +10.5% |
| Q2 FY2024 | Jun 30, 2024 | $14.01M | +15.0% |
| Q1 FY2024 | Mar 31, 2024 | $13.39M | +14.2% |
| Q4 FY2023 | Dec 31, 2023 | $13.41M | +19.5% |
| Q3 FY2023 | Sep 30, 2023 | $12.84M | +21.8% |
| Q2 FY2023 | Jun 30, 2023 | $12.19M | +20.2% |
| Q1 FY2023 | Mar 31, 2023 | $11.72M | +25.0% |
| Q4 FY2022 | Dec 31, 2022 | $11.22M | +21.3% |
| Q3 FY2022 | Sep 30, 2022 | $10.54M | +25.4% |
| Q2 FY2022 | Jun 30, 2022 | $10.14M | +38.3% |
| Q1 FY2022 | Mar 31, 2022 | $9.38M | +32.8% |
| Q4 FY2021 | Dec 31, 2021 | $9.25M | +43.6% |
| Q3 FY2021 | Sep 30, 2021 | $8.41M | +46.4% |
| Q2 FY2021 | Jun 30, 2021 | $7.33M | +48.7% |
| Q1 FY2021 | Mar 31, 2021 | $7.06M | +9.3% |
| Q4 FY2020 | Dec 31, 2020 | $6.44M | -21.0% |
| Q3 FY2020 | Sep 30, 2020 | $5.74M | -26.4% |
| Q2 FY2020 | Jun 30, 2020 | $4.93M | -33.1% |
| Q1 FY2020 | Mar 31, 2020 | $6.46M | +1.2% |
| Q4 FY2019 | Dec 31, 2019 | $8.15M | +28.2% |
| Q3 FY2019 | Sep 30, 2019 | $7.80M | +34.7% |
| Q2 FY2019 | Jun 30, 2019 | $7.37M | +30.0% |
| Q1 FY2019 | Mar 31, 2019 | $6.39M | +18.0% |
| Q4 FY2018 | Dec 31, 2018 | $6.36M | +25.5% |
| Q3 FY2018 | Sep 30, 2018 | $5.79M | +32.1% |
| Q2 FY2018 | Jun 30, 2018 | $5.67M | +32.1% |
| Q1 FY2018 | Mar 31, 2018 | $5.42M | +43.5% |
| Q4 FY2017 | Dec 31, 2017 | $5.06M | +8.1% |
| Q3 FY2017 | Sep 30, 2017 | $4.38M | – |
| Q2 FY2017 | Jun 30, 2017 | $4.29M | – |
| Q1 FY2017 | Mar 31, 2017 | $3.77M | – |
| Q4 FY2016 | Dec 31, 2016 | $4.69M | – |
See a number that looks wrong?